LCDAE: Data Augmented Ensemble Framework for Lung Cancer Classification.

Area of Science:

• Medical Imaging
• Artificial Intelligence
• Oncology

Background:

• Early-stage lung cancer detection significantly reduces patient fatality rates.
• Deep learning methods show promise in medical image analysis but often suffer from overfitting, leading to reduced performance.
• Existing computer-aided diagnostic techniques face challenges in achieving high accuracy for lung cancer classification.

Purpose of the Study:

• To introduce a novel framework, the Lung Cancer Data Augmented Ensemble (LCDAE), designed to address overfitting and enhance performance in lung cancer classification tasks.
• To improve the accuracy and reliability of deep learning models in identifying early-stage lung cancer.
• To present a comprehensive approach combining generative adversarial networks, ensemble learning, and hybrid data augmentation.

Main Methods:

• Development of the Lung Cancer Deep Convolutional Generative Adversarial Network (GAN) for synthesizing realistic lung cancer images.
• Implementation of a Data Augmented Ensemble model (DA-ENM) that ensembles six fine-tuned transfer learning models for robust training and validation.
• Integration of a Hybrid Data Augmentation (HDA) technique, combining various data augmentation strategies within the LCDAE framework.

Main Results:

• The proposed LCDAE framework achieved exceptional performance metrics, including 99.99% accuracy, 99.99% precision, and 99.99% F1-score.
• Comparative analysis demonstrated that LCDAE significantly outperforms existing state-of-the-art methods in lung cancer classification.
• The framework effectively mitigated the overfitting problem inherent in deep learning models for this task.

Conclusions:

• The LCDAE framework successfully overcomes overfitting issues in lung cancer classification through the strategic application of diverse data augmentation techniques.
• The proposed method establishes a new benchmark in performance for lung cancer detection compared to current state-of-the-art approaches.
• LCDAE offers a promising solution for improving early-stage lung cancer detection, potentially leading to better patient survival rates.